http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-940544-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3f4526fdbf9d019c69c6ba524b81a50 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 1994-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_696d5e460546b88ccbcd4c8c79a35482 |
| publicationDate | 1995-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-940544-A1 |
| titleOfInvention | Pharmaceutical products |
| abstract | A combination product of a class III Antiarrhythmic drug, especially (+)-Sotalol.HC1,and a class II Antiarrhythmic drug, (±)-Sotalol. Hcl is useful for cardioprotective effects. The product may be in an oral dosage form in a weight ratio of approximately 9 parts +)-Sotalol to 1 part (±)-Sotalol. |
| priorityDate | 1994-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.